These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10828317)

  • 21. Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes.
    Kuang YH; Lu Y; Liu YK; Liao LQ; Zhou XC; Qin QS; Jia XK; Wu LS; Zhu W; Chen X
    Eur J Pharmacol; 2018 Apr; 824():57-63. PubMed ID: 29382533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
    Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
    J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clastogenic effects of two tyrosine kinase inhibitors, tyrphostin 23 and tyrphostin 46, on a transformed (CHO-K1) and on a primary embryonic chinese hamster cell line (CHE).
    Bassi L; Buzzi R; Fiore M; Palitti F
    Mutagenesis; 2000 Jul; 15(4):341-7. PubMed ID: 10887214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrphostins and other tyrosine kinase inhibitors.
    Levitzki A; Mishani E
    Annu Rev Biochem; 2006; 75():93-109. PubMed ID: 16756486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular signalling by binding sites for the antipsoriatic agent monomethylfumarate on human granulocytes.
    Nibbering PH; Thio B; Bezemer AC; Beijersbergen RL; Zomerdijk TP
    Br J Dermatol; 1997 Jul; 137(1):65-75. PubMed ID: 9274627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
    Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
    Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear envelope localization of Ran-binding protein 2 and Ran-GTPase-activating protein 1 in psoriatic epidermal keratinocytes.
    Yasuda K; Sugiura K; Takeichi T; Ogawa Y; Muro Y; Akiyama M
    Exp Dermatol; 2014 Feb; 23(2):119-24. PubMed ID: 24438026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
    Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
    J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.
    Lei W; Mayotte JE; Levitt ML
    Anticancer Res; 1999; 19(1A):221-8. PubMed ID: 10226546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrphostins that suppress the growth of human papilloma virus 16-immortalized human keratinocytes.
    Ben-Bassat H; Rosenbaum-Mitrani S; Hartzstark Z; Levitzki R; Chaouat M; Shlomai Z; Klein BY; Kleinberger-Doron N; Gazit A; Tsvieli R; Levitzki A
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1442-57. PubMed ID: 10454524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lidocaine inhibits tyrosine kinase activity of the epidermal growth factor receptor and suppresses proliferation of corneal epithelial cells.
    Hirata M; Sakaguchi M; Mochida C; Sotozono C; Kageyama K; Kuroda Y; Hirose M
    Anesthesiology; 2004 May; 100(5):1206-10. PubMed ID: 15114219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity.
    Wijetunge S; Lymn JS; Hughes AD
    Br J Pharmacol; 2000 Apr; 129(7):1347-54. PubMed ID: 10742290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation.
    He H; Hirokawa Y; Manser E; Lim L; Levitzki A; Maruta H
    Cancer J; 2001; 7(3):191-202. PubMed ID: 11419027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of hypoxia-targeting protein tyrosine kinase inhibitor using an innovative pharmacophore 2-methylene-4-cyclopentene-1,3-dione.
    Hori H; Nagasawa H; Uto Y; Ohkura K; Kirk KL; Uehara Y; Shimamura M
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):29-38. PubMed ID: 15023348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of protein tyrosine kinase on regulation of trabecular meshwork and ciliary muscle contractility.
    Wiederholt M; Groth J; Strauss O
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1012-20. PubMed ID: 9579481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
    Klein JM; McCarthy TA
    Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structure-activity relationship, and p210(bcr-abl) protein tyrosine kinase activity of novel AG 957 analogs.
    Kaur G; Narayanan VL; Risbood PA; Hollingshead MG; Stinson SF; Varma RK; Sausville EA
    Bioorg Med Chem; 2005 Mar; 13(5):1749-61. PubMed ID: 15698792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
    Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
    Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.